Search Prime Grants

HT94252310955

Project Grant

Overview

Grant Description
Achieving homeostasis in traumatic injuries with a nitric oxide-driven antimicrobial dressing combined with a rapid blood clotting agent.
Awardee
Nytricx
Funding Goals
DEFENSE MEDICAL RESEARCH AND DEVELOPMENT PROGRAM AWARD MECHANISM: BATTLEFIELD WOUND MANAGEMENT AND INFECTION RESEARCH AWARD - FUNDING LEVEL 1
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Athens, Georgia 306021511 United States
Geographic Scope
Single Zip Code
Related Opportunity
W81XWH22DMRDPBWMIR
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/25 to 08/31/26.
Nytricx was awarded Project Grant HT94252310955 worth $1,114,225 from Defense Health Agency in September 2023 with work to be completed primarily in Athens Georgia United States. The grant has a duration of 3 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Complete)

Last Modified 9/22/25

Period of Performance
9/1/23
Start Date
8/31/26
End Date
100% Complete

Funding Split
$1.1M
Federal Obligation
$0.0
Non-Federal Obligation
$1.1M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to HT94252310955

Transaction History

Modifications to HT94252310955

Additional Detail

Award ID FAIN
HT94252310955
SAI Number
None
Award ID URI
None
Awardee Classifications
Small Business
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
GF9DV4ACBHH8
Awardee CAGE
9DZ67
Performance District
GA-10
Senators
Jon Ossoff
Raphael Warnock
Modified: 9/22/25